Twist Bioscience Corporation (TWST)
USD 44.61
(-7.83%)
USD 44.61
(-7.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -142.47 Million | -124.38 Million | -112.24 Million | -142.25 Million | -87.93 Million | -66.16 Million |
| Net Income | -204.61 Million | -217.86 Million | -152.09 Million | -139.93 Million | -107.66 Million | -71.23 Million |
| Depreciation & Amortization | 29.31 Million | 16.51 Million | 9.75 Million | 6.67 Million | 6.11 Million | 5.72 Million |
| Deferred income taxes | -410 Thousand | - | 630 Thousand | -214 Thousand | -1.06 Million | 42 Thousand |
| Stock-based compensation | 30.27 Million | 79.66 Million | 36.99 Million | 17.09 Million | 11.17 Million | 2.96 Million |
| Change in working capital | -1 Million | -5.35 Million | -9.38 Million | -25.17 Million | 2.99 Million | -4.22 Million |
| Other non-cash items | 3.97 Million | 2.65 Million | 1.85 Million | -707 Thousand | 515 Thousand | 562 Thousand |
| Investing Cash Flow | 50.61 Million | -232.93 Million | 156.15 Million | -114.65 Million | -104.81 Million | 26.87 Million |
| Investments in PPE | -27.77 Million | -101.85 Million | -27.06 Million | -9.86 Million | -14.75 Million | -3.68 Million |
| Acquisitions | 5.86 Million | -8.16 Million | -483 Thousand | 104.78 Million | 21 Thousand | 17 Thousand |
| Investment purchases | -76.34 Million | -217.63 Million | -58.79 Million | -202.88 Million | -177.57 Million | -3.52 Million |
| Sales/Maturities of investments | 154.73 Million | 100.48 Million | 242.49 Million | 98.1 Million | 87.5 Million | 34.5 Million |
| Other Investing Activities | -5.86 Million | -5.75 Million | 183.69 Million | -104.78 Million | -90.05 Million | -434 Thousand |
| Financing Cash Flow | 911 Thousand | 270.53 Million | 329.18 Million | 303.73 Million | 158.57 Million | 88.82 Million |
| Debt repayment | - | -1.55 Million | -3.33 Million | -3.33 Million | -2.5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4.4 Million | -7.75 Million | -10.84 Million | -2.42 Million | - | - |
| Common Stock Issuance | 5.31 Million | 269.82 Million | 343.36 Million | 309.48 Million | 156.2 Million | 331 Thousand |
| Other Financing Activities | 5.31 Million | 10.02 Million | 343.36 Million | 309.48 Million | 4.87 Million | 88.49 Million |
| Accounts receivables | -4.32 Million | -9.62 Million | -2.2 Million | -14.27 Million | -6.68 Million | -3.07 Million |
| Accounts payables | -2.5 Million | 7.38 Million | 8.54 Million | -5.5 Million | 3.27 Million | 3.75 Million |
| Inventory | 7.23 Million | -7.53 Million | -19.48 Million | -4.95 Million | -1.3 Million | -4.2 Million |
| Other working capital | -410 Thousand | 4.41 Million | 3.76 Million | -442 Thousand | 7.7 Million | -704 Thousand |
| Cash at beginning of period | 380.25 Million | 467.35 Million | 94.24 Million | 47.39 Million | 81.53 Million | 31.22 Million |
| Cash at end of period | 289.28 Million | 380.25 Million | 467.35 Million | 94.24 Million | 47.39 Million | 80.75 Million |
| Capital Expenditure | -27.77 Million | -101.85 Million | -27.06 Million | -9.86 Million | -14.75 Million | -3.68 Million |
| Effect of forex changes on cash | -27 Thousand | -319 Thousand | 20 Thousand | 21 Thousand | 30 Thousand | - |
| Net cash flow / Change in cash | -90.97 Million | -87.1 Million | 373.11 Million | 46.84 Million | -34.13 Million | 49.53 Million |
| Free Cash Flow | -170.25 Million | -226.24 Million | -139.3 Million | -152.12 Million | -102.69 Million | -69.85 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -85.57 Million | -45.49 Million | -43 Million | -46.24 Million | -204.61 Million | -57.39 Million |
| Depreciation & Amortization | 8.3 Million | 8.3 Million | 8.17 Million | 8.5 Million | 29.31 Million | 8.49 Million |
| Deferred income taxes | 191 Thousand | 345 Thousand | - | 221 Thousand | -410 Thousand | 3.62 Million |
| Stock-based compensation | 13.73 Million | 13.82 Million | 11.02 Million | 11.74 Million | 30.27 Million | 10.59 Million |
| Change in working capital | 12.56 Million | 3.45 Million | 532 Thousand | 441 Thousand | -1 Million | 12.01 Million |
| Other non-cash items | 70.24 Million | 32.6 Million | 312 Thousand | 4.63 Million | 3.97 Million | -739 Thousand |
| Investing Cash Flow | -711 Thousand | -5.24 Million | 4.16 Million | -2.24 Million | 50.61 Million | 18.67 Million |
| Investments in PPE | -965 Thousand | -603 Thousand | -1.5 Million | -2.39 Million | -27.77 Million | -4.5 Million |
| Acquisitions | - | - | - | -212.79 Million | 5.86 Million | -23.17 Million |
| Investment purchases | -1.74 Million | -10.63 Million | -18.32 Million | -18.09 Million | -76.34 Million | -7.82 Million |
| Sales/Maturities of investments | 2 Million | 6 Million | 24 Million | 18.23 Million | 154.73 Million | 31 Million |
| Other Investing Activities | 254 Thousand | -4.63 Million | 5.67 Million | 212.79 Million | -5.86 Million | 23.17 Million |
| Financing Cash Flow | 2.9 Million | 1.82 Million | -1.47 Million | 442 Thousand | 911 Thousand | -661 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -7000.00 | -1.53 Million | -2.42 Million | -1.13 Million | -4.4 Million | -1.01 Million |
| Common Stock Issuance | 2.91 Million | 3.36 Million | 951 Thousand | 1.57 Million | 5.31 Million | 353 Thousand |
| Other Financing Activities | 2.91 Million | 3.36 Million | 951 Thousand | 1.57 Million | 5.31 Million | 353 Thousand |
| Accounts receivables | 3.99 Million | -657 Thousand | 8.05 Million | -1.81 Million | -4.32 Million | 5.54 Million |
| Accounts payables | -1.2 Million | -1.52 Million | -4.2 Million | 1.92 Million | -2.5 Million | -220 Thousand |
| Inventory | 1.89 Million | 486 Thousand | 1.2 Million | 4.28 Million | 7.23 Million | 3.55 Million |
| Other working capital | 7.87 Million | 5.14 Million | -4.52 Million | -3.95 Million | -410 Thousand | 3.13 Million |
| Cash at beginning of period | 243.34 Million | 266.26 Million | 289.28 Million | 311.83 Million | 380.25 Million | 317.56 Million |
| Cash at end of period | 239.14 Million | 243.34 Million | 269.11 Million | 289.28 Million | 289.28 Million | 311.83 Million |
| Capital Expenditure | -965 Thousand | -603 Thousand | -1.5 Million | -2.39 Million | -27.77 Million | -4.5 Million |
| Effect of forex changes on cash | 2000.00 | -65 Thousand | 116 Thousand | -48 Thousand | -27 Thousand | -320 Thousand |
| Net cash flow / Change in cash | -4.2 Million | -22.92 Million | -20.16 Million | -22.55 Million | -90.97 Million | -5.72 Million |
| Free Cash Flow | -7.34 Million | -20.02 Million | -24.47 Million | -23.09 Million | -170.25 Million | -27.92 Million |
INDOCO
TTNNF
GARWSYN
2286
COIHF
B58